Equity Profile

ZBH

Zimmer Biomet Holdings, Inc.

Health CareHealth Care Equipment$17.1B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Zimmer Biomet Holdings, Inc. is a leading company in the health care equipment sector, specializing in orthopedic products and surgical solutions....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to increase sales and expand its market share, which is vital for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

ZBH Q2-2026 Earnings Preview

Context

Company Snapshot

Zimmer Biomet Holdings, Inc. is a leading company in the health care equipment sector, specializing in orthopedic products and surgical solutions. With a market cap of $17 billion, it plays a crucial role in improving patient outcomes through innovative medical technologies.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+2.87%

Avg Stock Reaction

-3.79%

Last Quarter Recap

In Q1-2026, Zimmer Biomet reported an EPS of $2.09, exceeding expectations by 12.55%. However, the stock dropped 10.57% the following day, indicating market concerns despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given the company's history of beating EPS estimates. However, the stock's recent volatility raises concerns about future performance.

Bull Case

If Zimmer Biomet continues its trend of beating EPS estimates, it could signal strong operational performance and boost investor confidence.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to further declines in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for this quarter?

Given the company's history of beating EPS estimates, this figure will be crucial in determining market sentiment and stock performance.

How is revenue growth trending compared to previous quarters?

Investors will closely watch revenue growth as it indicates the company's ability to expand its market presence and drive future profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate the potential for Zimmer Biomet to exceed EPS expectations due to strong demand for orthopedic products.

Supporting Evidence

The company's recent performance shows a consistent ability to beat EPS estimates, suggesting operational strength.

Options pricing indicates a significant expected move, which could reflect underlying investor confidence.

The historical trend of stock reactions suggests that even small beats can lead to larger stock movements.

Key Risk

If EPS comes in below $1.86, it could undermine the current bullish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it will reflect the company's operational strength and market conditions.

Bull Confirmed If

An EPS above $2.09 would confirm the bull case and suggest continued strong performance.

Bear Confirmed If

An EPS below $1.86 would confirm the bear case and raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±13.66%

Historical Avg

±7.7%

Pricing rich

The options market is pricing in a significant potential move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±13.7% while ZBH has averaged ±7.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

41.8%

Calls (12K)P/C Ratio: 0.43Puts (4K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Zimmer Biomet beats expectations, history suggests the stock could rise around 7.68% on the first day, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further commentary from management.

Miss

Should the company miss expectations, history suggests a potential drop of around 5.71%, indicating market disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's outlook on market conditions and demand for orthopedic products.
3Details on cost management strategies and their effect on margins.
4Insights into competitive positioning and market share trends.
5Any commentary on supply chain challenges and how they are being addressed.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Zimmer Biomet Holdings, Inc. is a leading company in the health care equipment sector, specializing in orthopedic products and surgical solutions....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to increase sales and expand its market share, which is vital for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

ZBH Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+2.87%

Avg Stock Reaction

-3.79%

Last Quarter Recap

In Q1-2026, Zimmer Biomet reported an EPS of $2.09, exceeding expectations by 12.55%. However, the stock dropped 10.57% the following day, indicating market concerns despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Zimmer Biomet continues its trend of beating EPS estimates, it could signal strong operational performance and boost investor confidence.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to further declines in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for this quarter?

Given the company's history of beating EPS estimates, this figure will be crucial in determining market sentiment and stock performance.

How is revenue growth trending compared to previous quarters?

Investors will closely watch revenue growth as it indicates the company's ability to expand its market presence and drive future profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate the potential for Zimmer Biomet to exceed EPS expectations due to strong demand for orthopedic products.

Supporting Evidence

The company's recent performance shows a consistent ability to beat EPS estimates, suggesting operational strength.

Options pricing indicates a significant expected move, which could reflect underlying investor confidence.

The historical trend of stock reactions suggests that even small beats can lead to larger stock movements.

Key Risk

If EPS comes in below $1.86, it could undermine the current bullish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it will reflect the company's operational strength and market conditions.

Bull Confirmed If

An EPS above $2.09 would confirm the bull case and suggest continued strong performance.

Bear Confirmed If

An EPS below $1.86 would confirm the bear case and raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±13.66%

Historical Avg

±7.7%

Pricing rich

The options market is pricing in a significant potential move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±13.7% while ZBH has averaged ±7.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

41.8%

Calls (12K)P/C Ratio: 0.43Puts (4K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Zimmer Biomet beats expectations, history suggests the stock could rise around 7.68% on the first day, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further commentary from management.

Miss

Should the company miss expectations, history suggests a potential drop of around 5.71%, indicating market disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's outlook on market conditions and demand for orthopedic products.
3Details on cost management strategies and their effect on margins.
4Insights into competitive positioning and market share trends.
5Any commentary on supply chain challenges and how they are being addressed.